eFFECTOR Therapeutics, Inc. financial data

Symbol
EFTR on OTC
Location
Solana Beach, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 09 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 93% % -27%
Debt-to-equity -1590% % -577%
Return On Equity 2178% %
Return On Assets -146% % -34%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,704,409 shares -89%
Common Stock, Shares, Outstanding 3,902,309 shares -91%
Common Stock, Value, Issued $0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 4,081,580 shares 143%
Weighted Average Number of Shares Outstanding, Diluted 4,081,580 shares 143%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $21,616,000 USD -19%
General and Administrative Expense $11,088,000 USD -8.6%
Operating Income (Loss) $32,704,000 USD 7.6%
Nonoperating Income (Expense) $1,927,000 USD -440%
Net Income (Loss) Attributable to Parent $34,631,000 USD 3.1%
Earnings Per Share, Basic -13 USD/shares 37%
Earnings Per Share, Diluted -13 USD/shares 36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $15,508,000 USD 50%
Cash, Cash Equivalents, and Short-term Investments $25,400,000 USD 34%
Assets, Current $26,250,000 USD 26%
Property, Plant and Equipment, Net $190,000 USD -11%
Operating Lease, Right-of-Use Asset $225,000 USD 132%
Assets $27,131,000 USD 24%
Accounts Payable, Current $1,713,000 USD -55%
Employee-related Liabilities, Current $978,000 USD 44%
Accrued Liabilities, Current $3,787,000 USD 48%
Liabilities, Current $25,569,000 USD -4.1%
Operating Lease, Liability, Noncurrent $179,000 USD 316%
Liabilities $26,304,000 USD -1.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $188,211,000 USD -23%
Stockholders' Equity Attributable to Parent $827,000 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $827,000 USD
Liabilities and Equity $27,131,000 USD 24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,278,000 USD 4.7%
Net Cash Provided by (Used in) Financing Activities $14,232,000 USD 6613%
Net Cash Provided by (Used in) Investing Activities $6,321,000 USD -170%
Common Stock, Shares Authorized 40,000,000 shares -96%
Common Stock, Shares, Issued 3,914,309 shares -91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $633,000 USD -60%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,508,000 USD 50%
Interest Paid, Excluding Capitalized Interest, Operating Activities $655,000 USD 11%
Operating Lease, Liability $232,000 USD 113%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $34,632,000 USD 3%
Property, Plant and Equipment, Gross $542,000 USD 18%
Operating Lease, Liability, Current $53,000 USD -20%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 50%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Operating Lease, Payments $105,000 USD 9.4%
Additional Paid in Capital $189,038,000 USD 27%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $28,000 USD 0%
Share-based Payment Arrangement, Expense $4,400,000 USD -19%
Interest Expense $2,979,000 USD 21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%